SHAYNA PERKINS: Open Payments
NPI 1699313650 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 79 payments from 18 companies in 2025. Trend: 2023 $1,998 · 2024 $305 · 2025 $1,419
Food & beverage: $1,419
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 34 | $395 |
| BETA BIONICS, INC. | 6 | $270 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| Tandem Diabetes Care, Inc. | 4 | $90 |
| Amgen Inc. | 5 | $89 |
| Lilly USA, LLC | 5 | $81 |
| Corcept Therapeutics | 4 | $79 |
| Sequel Med Tech, LLC | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $47 |
Products named: Ozempic, iLet Bionic Pancreas, Kerendia, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, Korlym, EVENITY, Rybelsus.
Industry payments across AL — which companies pay providers there.
